Phase 1 clinical trial using mbIL21 ex-vivo expanded donor-derived NK cells after haploidentical transplantation.
about
NK cell therapy after hematopoietic stem cell transplantation: can we improve anti-tumor effect?NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.Effect of IL-18 on the Expansion and Phenotype of Human Natural Killer Cells: Application to Cancer Immunotherapy.PD-L1 blockade enhances anti-tumor efficacy of NK cells
P2860
Phase 1 clinical trial using mbIL21 ex-vivo expanded donor-derived NK cells after haploidentical transplantation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Phase 1 clinical trial using m ...... aploidentical transplantation.
@en
type
label
Phase 1 clinical trial using m ...... aploidentical transplantation.
@en
prefLabel
Phase 1 clinical trial using m ...... aploidentical transplantation.
@en
P2093
P2860
P1433
P1476
Phase 1 clinical trial using m ...... aploidentical transplantation.
@en
P2093
Alison Gulbis
Cecele J Denman
Dana Willis
Dean A Lee
Doris Soebbing
Elizabeth J Shpall
Gabriela Rondon
Indreshpal Kaur
Jolie R Schafer
Julianne Chen
P2860
P356
10.1182/BLOOD-2017-05-785659
P407
P577
2017-08-23T00:00:00Z